Cantor Fitzgerald upgraded McEwen Mining (MUX) to Buy from Speculative Buy with an unchanged price target of $14.50 after the company completed ...

Cantor Fitzgerald initiated coverage of SAIC (SAIC) with a Neutral rating and $120 price target Maximize Your Portfolio with Data Driven ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Surgery Partners (NASDAQ:SGRY) with a steady price target of $36.00. The stock, which has shown significant momentum with a 20% ...

On Tuesday, Cantor Fitzgerald reiterated its confidence in ORIC Pharmaceuticals (NASDAQ:ORIC), maintaining an Overweight stock rating. Trading at $11.49, ORIC has seen analyst targets ranging from ...

Cantor Fitzgerald has a convertible bond with Tether, incoming Commerce Secretary Howard Lutnick said at his confirmation hearing, confirming previous reporting by The Wall Street Journal that ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC has several regulatory decisions this year ...

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is confident that Cigna can correct their stop-loss pricing ...

Cantor Fitzgerald currently has a “Neutral” rating and a $875.00 price target on the stock. The consensus estimate for KLA’s current full-year earnings is $30.80 per share. Get KLA alerts: ...

billionaire chairman and CEO of Wall Street firm Cantor Fitzgerald, to run the Commerce Department. The Senate Commerce Committee voted 16-12 with all Democrats except Senator John Fetterman ...

Howard Lutnick, the chairman of Cantor Fitzgerald and nominee for U.S. Commerce Secretary, faced questioning from Senate Democrats regarding the financial firm's investment in Tether, the entity ...

Amgen Inc. (NASDAQ:AMGN – Free Report) – Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to investors on Wednesday ...

Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (WBAG:LRC2) from Neutral to Overweight. There are 1,883 funds or institutions reporting positions ...